GLP1R and cancer: Moreover, although in vitro findings suggest cancer inhibition (by modulation cell growth, apoptosis, and angiogenesis) of GLP-1, doubts about potential tumorigenesis are still to be clarified, as liraglutide has been found to be associated with increased incidence of some types of cancer (e.g., breast, thyroid, and pancreatic carcinomas) [18].